Moderna | MRNA - Selling And Administration Expenses


Moderna reported $282M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Acadia Pharmaceuticals USD 146.88M 1.69M Sep/2026
Agios Pharmaceuticals USD 51.55M 13.09M Jun/2026
Alnylam Pharmaceuticals USD 342M 5.92M Sep/2026
Amgen USD 1.68B 40M Sep/2026
Arrowhead Research USD 46.63M 4.88M Jun/2026
Biogen USD 752M 42.3M Sep/2026
BioMarin Pharmaceutical USD 333.64M 61.91M Sep/2026
Celltrion KRW 12.72B 3.4B Jun/2026
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 13.56M 1.09M Jun/2026
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Gilead Sciences USD 1.52B 70M Jun/2026
GlaxoSmithKline GBP 2.16B 39M Sep/2026
Incyte USD 364.27M 12.54M Sep/2026
Ionis Pharmaceuticals USD 154M 23.92M Sep/2026
Kangmei Pharma CNY 253.72M 16.66M Jun/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Moderna USD 282M 66M Sep/2026
Organigram Holdings CAD 26.51M 4.5M Jun/2026
Ovoca Bio EUR 617K 15K Dec/2025
Pharma Mar EUR 15.53M 1.59M Sep/2026
Puma Biotechnology USD 16.82M 8.15M Sep/2024
Qiagen NV USD 142.33M 60K Jun/2026
Regeneron Pharmaceuticals USD 662.1M 14.4M Jun/2026
Sangamo BioSciences USD 9.64M 1.83M Jun/2024
Sarepta Therapeutics USD 118.61M 11.01M Sep/2026
Sartorius EUR 216.6M 4.7M Sep/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Tilray USD 24.85M 1.7M Sep/2025
Ultragenyx Pharmaceutical USD 97M 9M Sep/2026
United Therapeutics USD 184.1M 22.6M Sep/2026
Vertex Pharmaceuticals USD 556.3M 25.9M Sep/2026
Zealand Pharma A/S 104M 12.19M Mar/2026
Zz Pientze Pharmaceu CNY 267.85M 44.71M Sep/2026